Volltext verfügbar nach Anmeldung bzw. im Campus-Netz.
Sirnaomics to Present Latest Developments of STP705 for Focal Fat Reduction at IMCAS World Congress 2024
In: PR Newswire US, 2024-02-05
Online
Zeitungsartikel
Zugriff:
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, presented the latest developments on Polypeptide Nanoparticle (PNP) platform, and its pipeline program STP705 for Focal Fat Reduction's positive clinical data, at IMCAS World Congress 2024, which is taking place in Paris from February 1st - 3rd, 2024. [ABSTRACT FROM PUBLISHER]
Titel: |
Sirnaomics to Present Latest Developments of STP705 for Focal Fat Reduction at IMCAS World Congress 2024
|
---|---|
Autor/in / Beteiligte Person: | Newswire, PR |
Zeitschrift: | PR Newswire US, 2024-02-05 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|